Ignite Creation Date:
2024-05-06 @ 3:34 PM
Last Modification Date:
2024-10-26 @ 1:52 PM
Study NCT ID:
NCT04676516
Status:
COMPLETED
Last Update Posted:
2022-10-25
First Post:
2020-07-28
Brief Title:
A Phase II Window of Opportunity Trial of PRMT5 Inhibitor GSK3326595 in Early Stage Breast Cancer
Sponsor:
Ottawa Hospital Research Institute
Organization:
Ottawa Hospital Research Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-08
Start Date Type:
ACTUAL
Primary Completion Date:
2022-08-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-08-15
Completion Date Type:
ACTUAL
First Submit Date:
2020-07-28
First Submit QC Date:
December 18 2020
Study First Post Date:
2020-12-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-24
Last Update Post Date:
2022-10-25
Last Update Post Date Type:
ACTUAL